Swiss Insurance Stock News

Many investors define successful investing as beating the market average over the long term. But its virtually certain...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

In late 2025, Swedish utility Vattenfall and the Industrikraft i Sverige AB consortium, which includes ABB, agreed to co-invest about SEK 400 million in early-stage small modular reactor development at the Ringhals site via project company Videberg Kraft AB. This move highlights ABB’s role in nuclear-related industrial partnerships, potentially broadening its footprint in electrification projects tied to Sweden’s fossil-free power ambitions. We’ll now examine how ABB’s participation in...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Key Insights Given the large stake in the stock by institutions, Interroll Holding's stock price might be vulnerable to...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...

It's not a stretch to say that Kuehne + Nagel International AG's ( VTX:KNIN ) price-to-earnings (or "P/E") ratio of...

Key Insights The considerable ownership by private companies in DKSH Holding indicates that they collectively have a...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Roche Holding (SWX:ROG) has drawn investor interest after recent share price moves, with the stock showing positive returns over the past month and over the past 3 months, prompting a closer look at its current profile. See our latest analysis for Roche Holding. Roche Holding’s recent share price strength, including a 5.56% 1 month share price return and 13.76% 3 month share price return, sits alongside a 31.67% 1 year total shareholder return, suggesting momentum has been building rather...

If you are wondering whether Nestlé is still a solid long term hold or starting to look expensive at its current price, the key question is how today’s market value lines up with the fundamentals. The share price recently closed at CHF78.74, with a flat 7 day return of 0.0% and a small 30 day decline of 0.1%, while the 1 year return of 10.2% contrasts with a 3 year decline of 22.6% and a 5 year decline of 9.8%. Recent discussion around Nestlé has focused on how a global consumer staples...

Key Insights Given the large stake in the stock by institutions, BELIMO Holding's stock price might be vulnerable to...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Key Insights The projected fair value for Logitech International is CHF121 based on 2 Stage Free Cash Flow to Equity...

Key Insights Significant control over Sunrise Communications by individual investors implies that the general public...

As the pan-European STOXX Europe 600 Index edges closer to record highs amid optimism about future earnings and economic prospects, investors are keenly observing the high-growth tech sector, which remains a focal point of innovation and potential. In such an environment, identifying promising stocks often involves looking for companies with robust growth trajectories and adaptability to evolving technological trends, making them standouts in a dynamic market landscape.

As the pan-European STOXX Europe 600 Index edged slightly higher in a holiday-shortened week, optimism about future earnings and economic conditions has kept investor sentiment buoyant. In this environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to capitalize on market inefficiencies.

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Key Insights Institutions' substantial holdings in Galderma Group implies that they have significant influence over the...

Straumann Holding AG ( VTX:STMN ) received a lot of attention from a substantial price movement on the SWX over the...

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active...

EMS-CHEMIE HOLDING AG's ( VTX:EMSN ) price-to-earnings (or "P/E") ratio of 27.6x might make it look like a sell right...

Earlier this month, Genentech, a member of the Roche Group, received U.S. FDA accelerated approval for Lunsumio VELO, a subcutaneous formulation of mosunetuzumab for adults with relapsed or refractory follicular lymphoma after at least two prior systemic therapies, cutting administration time from hours to about one minute. This approval not only broadens Roche’s oncology offering but also highlights how treatment convenience and clinic efficiency are becoming core differentiators in cancer...

Alcon (SWX:ALC) has quietly outperformed the broader healthcare space over the past month, with shares climbing about 4% even as the stock remains down sharply year to date. See our latest analysis for Alcon. That recent 30 day share price return of 3.84% looks more like a stabilisation than a full reversal. The year to date share price is still down 16.42%, and the one year total shareholder return is negative but modestly positive over three years. If Alcon’s move has you reassessing the...